Editorial: New insights: developments in laboratory testing for the diagnosis and monitoring of endocrine related disorders and metabolic disease.
作者信息
Gounden Verena, Tanpaiboon Pranoot
机构信息
Department of Chemical Pathology, University of KwaZulu Natal, National Health Laboratory Service (NHLS), Johannesburg, South Africa.
Department of Biochemical Genetics, Quest Diagnostics (United States), Madison, NJ, United States.
出版信息
Front Endocrinol (Lausanne). 2024 Nov 29;15:1524950. doi: 10.3389/fendo.2024.1524950. eCollection 2024.
Abstract
摘要
相似文献
1
Editorial: New insights: developments in laboratory testing for the diagnosis and monitoring of endocrine related disorders and metabolic disease.社论：新见解：内分泌相关疾病和代谢性疾病诊断与监测的实验室检测进展
Front Endocrinol (Lausanne). 2024 Nov 29;15:1524950. doi: 10.3389/fendo.2024.1524950. eCollection 2024.
2
Editorial: Interaction of endocrine disorders and metabolic associated fatty liver disease: the genetic and epigenetic basis.社论：内分泌紊乱与代谢相关脂肪性肝病的相互作用：遗传和表观遗传基础
Front Endocrinol (Lausanne). 2023 Nov 7;14:1308860. doi: 10.3389/fendo.2023.1308860. eCollection 2023.
3
[Investigation of metabolic disorders in patients with familial fatty liver disease and their first-degree relatives].[家族性脂肪性肝病患者及其一级亲属的代谢紊乱调查]
Zhonghua Gan Zang Bing Za Zhi. 2016 Jun;24(6):435-40. doi: 10.3760/cma.j.issn.1007-3418.2016.06.008.
4
Metabolic phenotyping and systems biology approaches to understanding metabolic syndrome and fatty liver disease.代谢表型和系统生物学方法研究代谢综合征和脂肪肝。
Gastroenterology. 2014 Jan;146(1):46-62. doi: 10.1053/j.gastro.2013.11.001. Epub 2013 Nov 7.
5
Integrative Strategy of Testing Systems for Identification of Endocrine Disruptors Inducing Metabolic Disorders-An Introduction to the OBERON Project.内分泌干扰物诱导代谢紊乱检测系统的综合策略——OBERON 项目简介。
Int J Mol Sci. 2020 Apr 23;21(8):2988. doi: 10.3390/ijms21082988.
6
[Lab on a Chip].[芯片实验室]
Internist (Berl). 2019 Apr;60(4):339-344. doi: 10.1007/s00108-018-0526-y.
7
MAFLD as part of systemic metabolic dysregulation.MAFLD作为全身代谢失调的一部分。
Hepatol Int. 2024 Oct;18(Suppl 2):834-847. doi: 10.1007/s12072-024-10660-y. Epub 2024 Apr 9.
8
Ancestral bisphenol A exposure led to non-alcoholic fatty liver disease and sex-specific alterations in proline and bile metabolism pathways in the liver.祖先暴露于双酚A会导致非酒精性脂肪性肝病以及肝脏中脯氨酸和胆汁代谢途径的性别特异性改变。
Environ Toxicol Chem. 2025 Apr 1;44(4):958-972. doi: 10.1093/etojnl/vgae081.
9
[Role of the endocrine system in the pathogenesis of non-alcoholic fatty liver disease].[内分泌系统在非酒精性脂肪性肝病发病机制中的作用]
Orv Hetil. 2009 Nov 29;150(48):2173-81. doi: 10.1556/OH.2009.28749.
10
Metabolism-Disrupting Chemicals Affecting the Liver: Screening, Testing, and Molecular Pathway Identification.扰乱肝脏代谢的化学物质：筛选、测试和分子途径鉴定。
Int J Mol Sci. 2023 Jan 31;24(3):2686. doi: 10.3390/ijms24032686.
本文引用的文献
1
Non-alcoholic fatty liver disease.非酒精性脂肪性肝病。
Lancet. 2021 Jun 5;397(10290):2212-2224. doi: 10.1016/S0140-6736(20)32511-3. Epub 2021 Apr 21.
2
Global epidemiology of hyperthyroidism and hypothyroidism.全球甲状腺功能亢进症和甲状腺功能减退症的流行病学。
Nat Rev Endocrinol. 2018 May;14(5):301-316. doi: 10.1038/nrendo.2018.18. Epub 2018 Mar 23.
3
A selected history and future of immunoassay development and applications in clinical chemistry.免疫分析在临床化学中的发展历程与应用展望
Clin Chim Acta. 2006 Jul 23;369(2):119-24. doi: 10.1016/j.cca.2006.02.045. Epub 2006 Mar 27.
Zotero 插件